SCHEMBL502902

SCHEMBL502902

[CH2]C(O)C(F)(F)C=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10150500 0.73
SCHEMBL16077769 0.73 CPT2 (0.32)
SCHEMBL19551250 0.68
SCHEMBL3697794 0.68
SCHEMBL165046 0.68
SCHEMBL19577669 0.67
SCHEMBL191848 0.67
SCHEMBL21793693 0.65
SCHEMBL25144369 0.65
SCHEMBL15403184 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2949652-B1 Intermediates for the preparation of halichondrin B EISAI R&D MAN CO LTD (JP) 2019-08-07 EP disclosed
EP-2686441-B1 METHODS AND USES FOR PREDICTING RESPONSE TO ERIBULIN EISAI R&D MAN CO LTD (JP) 2019-05-08 EP disclosed
US-RE46965-E1 Intermediates for the preparation of analogs of Halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2018-07-24 US disclosed
US-9637795-B2 Methods and compositions for predicting response to eribulin EISAI R&D MANAGEMENT CO., LTD. (JP) 2017-05-02 US disclosed
US-9303050-B2 Intermediates for the preparation of analogs of Halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2016-04-05 US disclosed
EP-2949652-A1 Intermediates for the preparation of halichondrin B Eisai R&D Management Co., Ltd. (JP) 2015-12-02 EP disclosed
US-20150232490-A1 INTERMEDIATES FOR THE PREPARATION OF ANALOGS OF HALICHONDRIN B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-08-20 US disclosed
EP-2522663-B1 Intermediates for the preparation of halichondrin B EISAI R&D MAN CO LTD (JP) 2015-04-01 EP disclosed
US-8975422-B2 Intermediates for the preparation of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-03-10 US disclosed
US-RE45324-E1 Intermediates for the preparation of analogs of halichondrin B EISAI R&D MANAGEMENT CO., LTD. (JP) 2015-01-06 US disclosed
EP-1771431-A1 INTERMEDIATES FOR THE PREPARATION OF HALICHONDRIN B Eisai Co., Ltd. (JP) 2007-04-11 EP disclosed
EP-1653953-A2 DRUG DELIVERY METHODS AND DEVICES Eisai Co., Ltd. (JP) 2006-05-10 EP disclosed
WO-2005118565-A1 INTERMEDIATES FOR THE PREPARATION OF HALICHONDRIN B EISAI CO., LTD. (JP) 2005-12-15 WO disclosed
WO-2005011589-A2 DRUG DELIVERY METHODS AND DEVICES EISAI CO., LTD. (JP) 2005-02-10 WO disclosed
EP-1087960-A4 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO LTD (JP) 2004-12-01 EP disclosed
US-6469182-B1 HALICHONDRIN ANALOGS HAVING PHARMACEUTICAL ACTIVITY, SUCH AS ANTICANCER OR ANTIMITOTIC ACTIVITY EISAI CO., LTD. (JP) 2002-10-22 US disclosed
US-6365759-B1 ANTICARCINOGENIC AND ANTIMITOTIC AGENTS; STABLE; MELANOMA; LEUKEMIA; COLON; MAMMARY GLANDS; OVARIES; PROSTATE GLANDS; LUNGS EISAI CO., LTD. (JP) 2002-04-02 US disclosed
US-6214865-B1 Macrocyclic analogs and methods of their use and preparation EISAI CO., LTD. (JP) 2001-04-10 US disclosed
EP-1087960-A1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO., LTD. (JP) 2001-04-04 EP disclosed
WO-1999065894-A1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO., LTD. (JP) 1999-12-23 WO disclosed